Physician profile
Todd E Daynes
NPI 1053412494
$1,366.05
in general payments reported to CMS, 2019-2025
21 companies · $339 in 2025
The $339 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $254 · 2020: $45.90 · 2021: $105 · 2022: $159 · 2023: $186 · 2024: $278 · 2025: $339.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $802.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $802.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $322.91 | 2022-2025 | Cequa |
| Synergeyes, INC. | $220.54 | 2019 | |
| Abbvie INC. | $215.76 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $102.66 | 2020-2023 | |
| Apellis Pharmaceuticals, INC. | $61.04 | 2024-2025 | Syfovre |
| Alcon Vision LLC | $59.32 | 2024-2025 | Argos, Clareon, Precision 7 |
| Dompe US, INC. | $42.78 | 2021-2024 | Oxervate |
| Johnson & Johnson Surgical Vision, INC. | $34.89 | 2022-2023 | Lipiflow System Activator (Disposable) |
| Allergan, INC. | $32.99 | 2020-2021 | |
| Regeneron Healthcare Solutions, INC. | $32.77 | 2022 | |
| Tarsus Pharmaceuticals, INC. | $32.37 | 2024-2025 | Xdemvy |
| Coopervision INC. | $29.92 | 2023 | Paragon Crt |
| Spark Therapeutics, INC. | $28.48 | 2022 | |
| Shire North American Group INC | $24.82 | 2019 | |
| Horizon Therapeutics Plc | $24.26 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $23.85 | 2024 | Miebo, Xiidra |
| Rxsight INC | $19.59 | 2024 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Astellas Pharma US INC | $15.50 | 2025 | Izervay |
| Eyepoint US, INC. | $13.55 | 2021 | |
| Travere Therapeutics, INC. | $8.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Daynes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.